Results 91 to 100 of about 14,835 (171)

ROLE OF STATINS IN CIRRHOTIC PORTAL HYPERTENSION: META-ANALYSIS OF RANDOMIZED STUDIES. [PDF]

Arq Gastroenterol
Moreno MOA, Paz CLDSL, Rodrigues MAN, Andrade ACD, Dezan MGF, Cavalcante LN, Lyra AC.   +6 more
europepmc   +1 more source

The efficacy of carvedilol in improving cardiac function and survival in patients with anthracycline-induced cardiotoxicity: a comprehensive systematic review and meta-analysis. [PDF]

Int J Cardiol Heart Vasc
Abbasi SUAM, Bhagwan R, Rehman A, Malik N, Khaskheli SA, Rajpar NA, Nabi R, Basra AA, Meghwar S, Ahmed R, Singh K.   +10 more
europepmc   +1 more source

Case Report: Bilateral coronary ostial spasm triggered by iatrogenic thyrotoxicosis mimicking left main coronary artery disease. [PDF]

Front Cardiovasc Med
Choi HR, Bae JS, Cho YH, Jang JY, Park JR, Kang MG, Kim KH, Hwang JY, Ahn JH.   +8 more
europepmc   +1 more source

Comparative Effectiveness and Outcomes of Nebivolol Versus Other Beta Blockers in Patients With Hypertension: A Multicenter Cohort Study. [PDF]

J Am Heart Assoc
Chang YC, Lee KT, Ho WJ, Ling AW, Chu PH.   +4 more
europepmc   +1 more source

Case Report: A possible novel adult-onset, progressive MAO-A hypofunction. [PDF]

Front Neurosci
Berteau S, Armitano E.
europepmc   +1 more source

Repair of Ventricular Septal Defect in Children with <i>TAB2</i> Gene Anomalies and Associated Cardiomyopathy. [PDF]

Surg Case Rep
Ugaki S, Ogura S, Tsuno K, Shimizu T, Masuda S, Mafune R, Momoki K, Kawachi S, Hamaya I, Hoshino K, Nomura K.   +10 more
europepmc   +1 more source

Comparing the Molecular Pharmacological Properties of Existing β-Blockers to Determine the Theoretically Most "Ideal" Anti-Cancer β-Blocker. [PDF]

Pharmacol Res Perspect
Baker JG.
europepmc   +1 more source

Review on cardioprotective strategies in the setting of chemotherapy-induced cardiotoxicity. [PDF]

Cardiooncology
Dao V, Amin S, Kammaripalle T, Manning K.   +3 more
europepmc   +1 more source

The Spiked Helmet Sign: When ST-Segment Elevations Do Not Need the Cath Lab. [PDF]

JACC Case Rep
Patel A, Palla N, Abraham M, Petrovic L.
europepmc   +1 more source

Carvedilol decreases hepatic vascular resistance by reducing fibrogenesis and reversing endothelial dysfunction in cirrhotic rats. [PDF]

JHEP Rep
Nulan Y, Felli E, Selicean SE, Prampolini M, Berzigotti A, Gracia-Sancho J, Bosch J.   +6 more
europepmc   +1 more source